FAILURE OF RABIES POSTEXPOSURE TREATMENT WITH PURIFIED CHICK-EMBRYO CELL (PCEC) VACCINE

被引：5
|
作者：
MADHUSUDANA, SN
AGGARWAL, P
TRIPATHI, KK
机构：
来源：
VACCINE | 1989年 / 7卷 / 05期
关键词：
D O I：
10.1016/0264-410X(89)90185-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [21] Protecting Indian schoolchildren against rabies - Pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV)
    Shanbag, Preeti
    Shah, Nitin
    Kulkarni, Madhuri
    Juvekar, Manisha
    Madhusudana, S. N.
    Vakil, Hoshang B.
    Malerczyk, Claudius
    HUMAN VACCINES, 2008, 4 (05): : 365 - 369
  • [22] Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe
    Kamoltham, Thavatchai
    Thinyounyong, Wirawan
    Phongchamnaphai, Phana
    Phraisuwan, Phran
    Khawplod, Pakamatz
    Banzhoff, Angelika
    Malerczyk, Claudius
    JOURNAL OF PEDIATRICS, 2007, 151 (02): : 173 - 177
  • [23] Duration of immunity: An anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine
    Malerczyk, Claudius
    Briggs, Deborah J.
    Dreesen, David W.
    Banzhoff, Angelika
    JOURNAL OF TRAVEL MEDICINE, 2007, 14 (01) : 63 - 64
  • [24] Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin
    Goel, SK
    Sharma, S
    Singh, US
    BIOLOGICALS, 2003, 31 (04) : 233 - 236
  • [25] Response to purified chick embryo cell rabies vaccine administered intradermally for post-exposure prophylaxis
    Madhusudana, SN
    Anand, NP
    NATIONAL MEDICAL JOURNAL OF INDIA, 1997, 10 (03): : 115 - 116
  • [26] ADVERSE EVENTS FOLLOWING PURIFIED CHICK EMBRYO CELL (PCEC, RABAVERT®) VACCINE IN THE VACCINE ADVERSE EVENT REPORTING SYSTEM, 2006-2015
    Moro, Pedro L.
    Lewis, Paige
    Cano, Maria
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 337 - 337
  • [27] Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults
    Phadke, Varun K.
    Gromer, Daniel J.
    Rebolledo, Paulina A.
    Graciaa, Daniel S.
    Wiley, Zanthia
    Sherman, Amy C.
    Scherer, Erin M.
    Leary, Maranda
    Girmay, Tigisty
    Mccullough, Michele P.
    Min, Ji-Young
    Capone, Stefania
    Sommella, Andrea
    Vitelli, Alessandra
    Retallick, Jamie
    Seetahal, Janine
    Koller, Mark
    Tsong, Rachel
    Neill-Gubitz, Hannah
    Mulligan, Mark J.
    Rouphael, Nadine G.
    VACCINE, 2024, 42 (26)
  • [28] 2-YEAR COMPARATIVE TRIAL ON THE IMMUNOGENICITY AND ADVERSE-EFFECTS OF PURIFIED CHICK-EMBRYO CELL RABIES VACCINE FOR PRE-EXPOSURE IMMUNIZATION
    DREESEN, DW
    FISHBEIN, DB
    KEMP, DT
    BROWN, J
    VACCINE, 1989, 7 (05) : 397 - 400
  • [29] Promising Rabies Vaccine for Postexposure Prophylaxis in Developing Countries, a Purified Vero Cell Vaccine Produced in China
    Wang, Chuanlin
    Zhang, Xiaowei
    Song, Qingkun
    Tang, Kun
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (04) : 688 - 690
  • [30] FAILURE OF RABIES POSTEXPOSURE TREATMENT IN THAILAND
    WILDE, H
    CHOOMKASIEN, P
    HEMACHUDHA, T
    SUPICH, C
    CHUTIVONGSE, S
    VACCINE, 1989, 7 (01) : 49 - 52
12345